Education
About Us
Working with TipRanks
Follow Us
Electrocore Llc (ECOR)
NASDAQ:ECOR
ECOR Stock Chart & Stats
$6.55
$0.45(2.64%)
At close: 4:00 PM EST
$6.55
$0.45(2.64%)
Day’s Range― - ―
52-Week Range$4.16 - $19.49
Previous CloseN/A
Volume24.66K
Average Volume (3M)33.66K
Market Cap
$52.37M
Enterprise Value$39.41M
Total Cash (Recent Filing)$13.20M
Total Debt (Recent Filing)$10.81M
Price to Earnings (P/E)―
Beta1.75
Next Earnings
Mar 05, 2026EPS Estimate
-0.39Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.40
Shares Outstanding7,995,903
10 Day Avg. Volume29,982
30 Day Avg. Volume33,656
Financial Highlights & Ratios
PEG Ratio0.19
Price to Book (P/B)16.08
Price to Sales (P/S)4.82
P/FCF Ratio-17.46
Enterprise Value/Market Cap0.75
Enterprise Value/Revenue1.32
Enterprise Value/Gross Profit1.54
Enterprise Value/Ebitda-3.11
Forecast
1Y Price Target
$18.50Price Target Upside182.44% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Product TractionQuell's initial sales exceeded expectations and strong early adoption suggests the product can meaningfully boost revenue as market penetration increases.
Profitability OutlookExpectation to achieve the first quarter of positive adjusted EBITDA in the second half of 2026 signals improving margins and progress toward sustainable profitability.
VA/DoD Channel ExpansionGrowth in VA and DoD prescribing facility count expands a key market channel and may drive higher device prescriptions and revenue.
Bears Say
Operating Expense PressureHigher anticipated operating expenses are likely to delay profitability and justify a discounted valuation until cost trends show sustained improvement.
Electrocore News
ECOR FAQ
What was Electrocore Llc’s price range in the past 12 months?
Electrocore Llc lowest stock price was $4.16 and its highest was $19.49 in the past 12 months.
What is Electrocore Llc’s market cap?
Electrocore Llc’s market cap is $52.37M.
When is Electrocore Llc’s upcoming earnings report date?
Electrocore Llc’s upcoming earnings report date is Mar 05, 2026 which is in 48 days.
How were Electrocore Llc’s earnings last quarter?
Electrocore Llc released its earnings results on Nov 05, 2025. The company reported -$0.4 earnings per share for the quarter, the consensus estimate of -$0.4 by $0.
Is Electrocore Llc overvalued?
According to Wall Street analysts Electrocore Llc’s price is currently Undervalued.
Does Electrocore Llc pay dividends?
Electrocore Llc does not currently pay dividends.
What is Electrocore Llc’s EPS estimate?
Electrocore Llc’s EPS estimate is -0.39.
How many shares outstanding does Electrocore Llc have?
Electrocore Llc has 7,995,903 shares outstanding.
What happened to Electrocore Llc’s price movement after its last earnings report?
Electrocore Llc reported an EPS of -$0.4 in its last earnings report, expectations of -$0.4. Following the earnings report the stock price went up 23.207%.
Which hedge fund is a major shareholder of Electrocore Llc?
Currently, no hedge funds are holding shares in ECOR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Electrocore Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$18.50 (182.44% Upside)
$18.50 (182.44% Upside)
Insider Transactions
Sold Shares
Worth $21.2K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.4%
Last 30 Days ▼ 5.6%
Last 30 Days ▼ 5.6%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-61.72%
12-Months-Change
Fundamentals
Return on Equity
-337.84%
Trailing 12-Months
Asset Growth
1.74%
Trailing 12-Months
Company Description
Electrocore Llc
electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld device for regular or intermittent use over many years. The company was incorporated in 2005 and is headquartered in Rockaway, New Jersey.
ECOR Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted strong revenue growth and successful strategic initiatives such as the NeuroMetrix acquisition and expansion in the VA system. However, these were balanced by increased net losses, delayed profitability, and ongoing legal challenges. Overall, the company is investing heavily in its future, which may pay off, but current financials are impacted.View all ECOR earnings summariesECOR Stock 12 Month Forecast
Average Price Target
$18.50
▲(182.44% Upside)
Technical Analysis
Myomo
―
Modular Medical
―
NeuroOne Medical Technologies
―
Vivos Therapeutics
―
Adagio Medical Holdings
―
Ownership Overview
20.81% Insiders
3.48% Mutual Funds
1.76% Other Institutional Investors
71.27% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---